Bruker Announces the Designation and Certification of its RAID-M Handheld Chemical Detector Under the SAFETY ACT as an Approved
30 January 2006 - 11:00PM
Business Wire
Bruker Daltonics NBC Detection Corp., an operating company of
Bruker BioSciences Corporation (NASDAQ: BRKR), today announces that
the Department of Homeland Security has granted Designation and
Certification of the RAID-M as an approved product under the
Support Anti-terrorism by Fostering Effective Technologies Act of
2002 (the SAFETY Act). The RAID-M received both Designation as a
Qualified Anti-Terrorism Technology and Certification as an
Approved Product for Homeland Security. This is the culmination of
a vigorous and meticulous evaluation of the efficacy of the RAID-M
that took several months. Frank Thibodeau, Vice President,
commented: "This Certification by the Department of Homeland
Security is more evidence that the RAID-M is considered by many to
be the best handheld chemical detector in the world today. It is
really a great tool in the hands of our country's first responders.
Along with many independent tests by government agencies around the
world, the DHS Certification lends even more credibility and
confidence in the RAID-M as the premier chemical and toxic
industrial detector on the market." By receiving the Designation
and Certification, Bruker Daltonics, its customers and its
suppliers will enjoy significant product liability protections
under the Safety Act. ABOUT BRUKER BIOSCIENCES Bruker BioSciences,
headquartered in Billerica, Massachusetts, is the publicly traded
parent company of Bruker Daltonics Inc. and Bruker AXS Inc. Bruker
Daltonics is a leading developer and provider of innovative life
science tools based on mass spectrometry. Bruker AXS is a leading
developer and provider of life science and advanced materials
research tools based on X-ray technology. For more information
about Bruker BioSciences Corporation, please visit
www.bruker-biosciences.com CAUTIONARY STATEMENT Any statements
contained in this press release that do not describe historical
facts may constitute forward-looking statements as that term is
defined in the Private Securities Litigation Reform Act of 1995.
Any forward-looking statements contained herein are based on
current expectations, but are subject to a number of risks and
uncertainties. The factors that could cause actual future results
to differ materially from current expectations include, but are not
limited to, risks and uncertainties relating to the companies'
reorganization strategies, integration risks, failure of
conditions, technological approaches, product development, market
acceptance, cost and pricing of the companies' products, changes in
governmental regulations, capital spending and government funding
policies, FDA and other regulatory approvals to the extent
applicable, competition, the intellectual property of others,
patent protection and litigation. These and other factors are
identified and described in more detail in our filings with the
SEC, including, without limitation, our respective annual reports
on Form 10-K for the year ended December 31, 2004, our most recent
quarterly reports on Form 10-Q, our current reports on Form 8-K and
the joint proxy statement/prospectus filed in connection with the
merger. We disclaim any intent or obligation to update these
forward-looking statements.
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2024 to Aug 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Aug 2023 to Aug 2024